Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 6/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | CYSLTR2 | Q9NS75 | 5/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8801669 | 0.90 | CYSLTR1 (0.54) | CYSLTR1CYSLTR2ALOX5GPBAR1 | |
| SCHEMBL8800823 | 0.82 | CYSLTR1 (0.48) | CYSLTR1FFAR1AKR1B1CYSLTR2ALOX5 | |
| SCHEMBL8800332 | 0.80 | CYSLTR1 (0.51) | CYSLTR1FFAR1AKR1B1CYSLTR2ALOX5 | |
| SCHEMBL8801873 | 0.77 | MAOB (0.58) | CYSLTR1FFAR1AKR1B1CYSLTR2PDE10A | |
| SCHEMBL6584872 | 0.75 | DRD2 (0.48) | — | |
| SCHEMBL10544473 | 0.75 | CYSLTR1 (0.84) | CYSLTR1FFAR1AKR1B1CYSLTR2ALOX5 | |
| SCHEMBL6586928 | 0.74 | MAOA (0.45) | — | |
| SCHEMBL8800538 | 0.74 | CYSLTR1 (0.51) | CYSLTR1CYSLTR2ALOX5GPBAR1 | |
| SCHEMBL9022146 | 0.73 | GPBAR1 (0.66) | CYSLTR1FFAR1AKR1B1CYSLTR2ALOX5 | |
| SCHEMBL8308890 | 0.73 | DRD2 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0799826-A1 | Heteroaryl substituted phenylene derivatives, their preparation and their use as leukotriene receptor antagonists | KOWA CO. LTD. (JP) | 1997-10-08 | — | — | EP | disclosed |